• 1
    Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90(8): 28632892.
  • 2
    Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol 2001; 38(2): 124138.
  • 3
    Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9(10): 17831786.
  • 4
    Roederer M, Hardy RR. Frequency difference gating: a multivariate method for identifying subsets that differ between samples. Cytometry 2001; 45(1): 5664.
  • 5
    Roederer M, Kantor AB, Parks DR, Herzenberg LA. Cy7PE and Cy7APC: bright new probes for immunofluorescence. Cytometry 1996; 24(3): 191197.
  • 6
    Basso G, Buldini B, De Zen L, Orfao A. New methodologic approaches for immunophenotyping acute leukemias. Haematologica 2001; 86(7): 675692.
  • 7
    Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 2000; 243(1–2): 7797.
  • 8
    Owens MA, Vall HG, Hurley AA, Wormsley SB. Validation and quality control of immunophenotyping in clinical flow cytometry. J Immunol Methods 2000; 243(1–2): 3350.
  • 9
    Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia 1996; 10(5): 877895.
  • 10
    Braylan RC, Atwater SK, Diamond L, Hassett JM, Johnson M, Kidd PG, Leith C, Nguyen D. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Cytometry 1997; 30(5): 245248.
  • 11
    Braylan RC, Orfao A, Borowitz MJ, Davis BH. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry 2001; 46(1): 2327.
  • 12
    Ruiz Arguelles A, Duque RE, Orfao A. Report on the first Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia. Cytometry 1998; 34(1): 3942.
  • 13
    Davis BH, Foucar K, Szczarkowski W, Ball E, Witzig T, Foon KA, Wells D, Kotylo P, Johnson R, Hanson C, Bessman D. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry 1997; 30(5): 249263.
  • 14
    Borowitz MJ, Bray R, Gascoyne R, Melnick S, Parker JW, Picker L, Stetler Stevenson M. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 1997; 30(5): 236244.
  • 15
    NCCLS. Clinical applications of flow cytometry: quality assurance and immunophenotyping of lymphocytes. NCCLS H42-A. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
  • 16
    NCCLS. Clinical applications of flow cytometry: immunophenotyping of leukemic cells; NCCLS H43-A. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
  • 17
    Gratama JW, Kraan J, Adriaansen H, Hooibrink B, Levering W, Reinders P, Van den Beemd MW, Van der Holt B, Bolhuis RL. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis. Cytometry 1997; 30(1): 1022.
  • 18
    Gratama JW, Kraan J, Van den Beemd R, Hooibrink B, Van Bockstaele DR, Hooijkaas H. Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study. Cytometry 1997; 30(4): 166177.
  • 19
    Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol 2000; 108(4): 784792.
  • 20
    Gratama JW, Bolhuis RL, Van 't Veer MB. Quality control of flow cytometric immunophenotyping of haematological malignancies. Clin Lab Haematol 1999; 21(3): 155160.
  • 21
    Kluin Nelemans J, Van Wering E, Van Der Schoot C, Adriaansen H, Van'T Veer M, Van Dongen J, Gratama J. SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance. Br J Haematol 2001; 112(2): 337343.
  • 22
    Kluin Nelemans JC, van Wering ER, van'T Veer MB, van der Schoot CE, Adriaansen HJ, van der Burgh FJ, Gratama JW. Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in The Netherlands. Dutch Cooperative Study Group on Immunophenotyping of Haematological Malignancies (SIHON). Br J Haematol 1996; 95(4): 692699.
  • 23
    Orfao A, Schmitz G, Brando B, Ruiz Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem 1999; 45(10): 17081717.
  • 24
    Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents 2003; 17(3): 223233.
  • 25
    Westgard JO, Groth T. A predictive value model for quality control: effects of the prevalence of errors on the performance of control procedures. Am J Clin Pathol 1983; 80(1): 4956.
  • 26
    Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, Reiffers J, Boisseau MR, Bernard P. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 1997; 11(11): 18781886.
  • 27
    Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26(1): 1621.
  • 28
    Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.
  • 29
    Sun T, Sangaline R, Ryder J, Gibbens K, Rollo C, Stewart S, Rajagopalan C. Gating strategy for immunophenotyping of leukemia and lymphoma. Am J Clin Pathol 1997; 108(2): 152157.
  • 30
    Schnizlein Bick CT, Mandy FF, O'Gorman MR, Paxton H, Nicholson JK, Hultin LE, Gelman RS, Wilkening CL, Livnat D. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 2002; 50(2): 4652.
  • 31
    Ratei R, Sperling C, Karawajew L, Schott G, Schrappe M, Harbott J, Riehm H, Ludwig WD. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Ann Hematol 1998; 77(3): 107114.
  • 32
    Vogt RF,Jr., Cross GD, Phillips DL, Henderson LO, Hannon WH. Interlaboratory study of cellular fluorescence intensity measurements with fluorescein-labeled microbead standards. Cytometry 1991; 12(6): 525536.
  • 33
    Margolick JB, Scott ER, Chadwick KR, Shapiro HM, Hetzel AD, Smith SJ, Vogt RF,Jr. Comparison of lymphocyte immunophenotypes obtained simultaneously from two different data acquisition and analysis systems on the same flow cytometer. Cytometry 1992; 13(2): 198203.